The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma

NCT02449278 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

RADIATION: Consolidation involved-site radiotherapy (ISRT)
RADIATION: Consolidation involved-field radiotherapy (IFRT)
DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: vincristine
DRUG: prednisone

Sponsor

Wuhan University